LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 173

Search options

  1. Article ; Online: Relevance of acquired T cell molecular defects in the immunopathogenesis of SLE.

    Rosetti, Florencia / Madera-Salcedo, Iris K / Crispín, José C

    Clinical immunology (Orlando, Fla.)

    2024  Volume 263, Page(s) 110225

    Abstract: Systemic lupus erythematosus (SLE) and other autoimmune diseases are thought to develop in genetically predisposed individuals when triggered by environmental factors. This paradigm does not fully explain disease development, as it fails to consider the ... ...

    Abstract Systemic lupus erythematosus (SLE) and other autoimmune diseases are thought to develop in genetically predisposed individuals when triggered by environmental factors. This paradigm does not fully explain disease development, as it fails to consider the delay between birth and disease expression. In this review, we discuss observations described in T cells from patients with SLE that are not related to hereditary factors and have therefore been considered secondary to the disease process itself. Here, we contextualize some of those observations and argue that they may represent a pathogenic layer between genetic factors and disease development. Acquired changes in T cell phenotype and function in the setting of SLE may affect the immune system, creating a predisposition towards a more inflammatory and pathogenic system that amplifies autoimmunity and facilitates disease development.
    Language English
    Publishing date 2024-04-18
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1459903-x
    ISSN 1521-7035 ; 1521-6616
    ISSN (online) 1521-7035
    ISSN 1521-6616
    DOI 10.1016/j.clim.2024.110225
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: UNWINDING THE LONG ROAD THAT LEADS TO UNDERSTANDING AUTOIMMUNITY.

    Rosetti, Florencia / Crispín, José C

    Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion

    2021  Volume 73, Issue 5, Page(s) 297–301

    Abstract: Systemic autoimmune diseases are complex clinical conditions that arise in genetically predisposed individuals as a result of the interplay between their immune system and their environment. In this perspective, we briefly discuss our current ... ...

    Abstract Systemic autoimmune diseases are complex clinical conditions that arise in genetically predisposed individuals as a result of the interplay between their immune system and their environment. In this perspective, we briefly discuss our current understanding of the pathogenesis of autoimmunity and indicate four research avenues whose exploration will bring us closer to resolving fundamental questions that remain unanswered in this enigmatic field.
    MeSH term(s) Autoimmune Diseases/genetics ; Autoimmune Diseases/immunology ; Autoimmune Diseases/pathology ; Autoimmunity/genetics ; Genetic Predisposition to Disease ; Humans
    Language English
    Publishing date 2021-10-05
    Publishing country Mexico
    Document type Journal Article
    ZDB-ID 138348-6
    ISSN 0034-8376
    ISSN 0034-8376
    DOI 10.24875/RIC.21000294
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Meta-analysis to Implement Alpha-Synuclein in Extracellular Vesicles as a Potential Biomarker for Parkinsons Disease.

    Juárez-Vaquera, Víctor H / Rosetti-Sciutto, Marcos F / Morales-Ruiz, Valeria / Adalid-Peralta, Laura V

    Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion

    2023  Volume 75, Issue 4, Page(s) 193–202

    Abstract: Background: ...

    Abstract Background:
    MeSH term(s) Humans ; alpha-Synuclein ; Biomarkers ; Extracellular Vesicles ; Parkinson Disease/diagnosis
    Chemical Substances alpha-Synuclein ; Biomarkers ; SNCA protein, human
    Language English
    Publishing date 2023-08-22
    Publishing country Mexico
    Document type Meta-Analysis ; Journal Article
    ZDB-ID 138348-6
    ISSN 0034-8376
    ISSN 0034-8376
    DOI 10.24875/RIC.23000017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Understanding the Relationship Between Depression Symptom Severity and Health Care Costs for Patients With Treatment-Resistant Depression.

    Lynch, Frances L / Dickerson, John F / O'Keeffe-Rosetti, Maureen / Chow, Wing / Pesa, Jacqueline

    The Journal of clinical psychiatry

    2022  Volume 83, Issue 2

    Abstract: Objective:: Methods:: Results:: Conclusions: ...

    Abstract Objective:
    Methods:
    Results:
    Conclusions:
    MeSH term(s) Adult ; Aged ; Cohort Studies ; Delivery of Health Care, Integrated/economics ; Depressive Disorder, Major/economics ; Depressive Disorder, Treatment-Resistant/economics ; Facilities and Services Utilization/economics ; Female ; Health Care Costs ; Humans ; Male ; Middle Aged ; Patient Acceptance of Health Care ; Patient Acuity ; Patient Health Questionnaire ; Retrospective Studies
    Language English
    Publishing date 2022-02-01
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 716287-x
    ISSN 1555-2101 ; 0160-6689
    ISSN (online) 1555-2101
    ISSN 0160-6689
    DOI 10.4088/JCP.21m13976
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: The Tower Building Task: A Behavioral Tool to Evaluate Recreational Risk-Taking.

    Gracia-Garrido, Santiago / Rosetti, Marcos F / Muñoz Navarrete, Kevin / Hudson, Robyn

    Behavioral sciences (Basel, Switzerland)

    2022  Volume 12, Issue 9

    Abstract: Risk-taking is a fundamental aspect of life spanning diverse contexts. Despite many tests being readily available, the behavioral assessment of risk propensity in recreational contexts, where decisions are not necessarily motivated by monetary gains or ... ...

    Abstract Risk-taking is a fundamental aspect of life spanning diverse contexts. Despite many tests being readily available, the behavioral assessment of risk propensity in recreational contexts, where decisions are not necessarily motivated by monetary gains or losses, is not well represented. As the tower building task (TBT) shares features of recreational activities, we evaluated whether it could assess risk-taking in this type of scenario. In the TBT, participants use standard-size wooden blocks to build the tallest tower they can within a 10 min period. In the current study we (i) examined methodological modifications to the task to either promote or reduce risky behavior and (ii) tested possible associations between the TBT scores and those of two commonly used risk-taking evaluations: The Balloon Analogue Risk Task (BART) and the Sensation Seeking Scale (SSS). We found that limiting the number of permitted collapses decreased the willingness to take risks, whereas challenging participants to exceed a "record" height increased risk-taking. TBT scores of one of the conditions correlated with scores of the BART and the SSS, particularly with the subscale addressing recreational activities. These findings suggest that the TBT offers a potentially useful means of evaluating risk-taking behaviors akin to those of the recreational domain.
    Language English
    Publishing date 2022-09-08
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2651997-5
    ISSN 2076-328X
    ISSN 2076-328X
    DOI 10.3390/bs12090325
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Regulation of activated T cell survival in rheumatic autoimmune diseases.

    Rosetti, Florencia / Madera-Salcedo, Iris K / Rodríguez-Rodríguez, Noé / Crispín, José C

    Nature reviews. Rheumatology

    2022  Volume 18, Issue 4, Page(s) 232–244

    Abstract: Adaptive immune responses rely on the proliferation of T lymphocytes able to recognize and eliminate pathogens. The magnitude and duration of the expansion of activated T cell clones are finely regulated to minimize immunopathology and avoid autoimmunity. ...

    Abstract Adaptive immune responses rely on the proliferation of T lymphocytes able to recognize and eliminate pathogens. The magnitude and duration of the expansion of activated T cell clones are finely regulated to minimize immunopathology and avoid autoimmunity. In patients with rheumatic autoimmune diseases, such as systemic lupus erythematosus and rheumatoid arthritis, activated lymphocytes survive and exert effector functions for prolonged periods, defying the mechanisms that normally curb their capacities during acute and chronic infections. Here, we review the molecular mechanisms that limit the duration of immune responses in health and discuss the factors that alter such regulation in the setting of systemic lupus erythematosus and rheumatoid arthritis. We highlight defects that could contribute to the development and progression of autoimmune disease and describe how chronic inflammation can alter the regulation of activated lymphocyte survival, promoting its perpetuation. These concepts might contribute to the understanding of the mechanisms that underlie the chronicity of inflammation in the context of autoimmunity.
    MeSH term(s) Arthritis, Rheumatoid ; Autoimmune Diseases ; Autoimmunity ; Cell Survival ; Humans ; Inflammation ; Lupus Erythematosus, Systemic ; Rheumatic Diseases ; T-Lymphocytes
    Language English
    Publishing date 2022-01-24
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2491532-4
    ISSN 1759-4804 ; 1759-4790
    ISSN (online) 1759-4804
    ISSN 1759-4790
    DOI 10.1038/s41584-021-00741-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Intrathecal anti-suprabasin antibodies in SLE, a cause of local concern?

    Rosetti, Florencia / Crispín, José C

    Clinical immunology (Orlando, Fla.)

    2017  Volume 193, Page(s) 131–132

    MeSH term(s) Autoantibodies ; Humans ; Lupus Erythematosus, Systemic ; Lupus Vasculitis, Central Nervous System
    Chemical Substances Autoantibodies
    Language English
    Publishing date 2017-11-29
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 1459903-x
    ISSN 1521-7035 ; 1521-6616
    ISSN (online) 1521-7035
    ISSN 1521-6616
    DOI 10.1016/j.clim.2017.11.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Transient inhibition of sodium-glucose cotransporter 2 after ischemia/reperfusion injury ameliorates chronic kidney disease.

    Martínez-Rojas, Miguel Ángel / Balcázar, Hiram / González-Soria, Isaac / González-Rivera, Jesús Manuel / Rodríguez-Vergara, Mauricio E / Velazquez-Villegas, Laura A / León-Contreras, Juan Carlos / Pérez-Villalva, Rosalba / Correa, Francisco / Rosetti, Florencia / Bobadilla, Norma A

    JCI insight

    2024  Volume 9, Issue 6

    Abstract: Sodium-glucose cotransporter 2 (SGLT2) inhibitor, dapagliflozin (Dapa), exhibited nephroprotective effects in patients with chronic kidney disease (CKD). We assessed the efficacy of short-term Dapa administration following acute kidney injury (AKI) in ... ...

    Abstract Sodium-glucose cotransporter 2 (SGLT2) inhibitor, dapagliflozin (Dapa), exhibited nephroprotective effects in patients with chronic kidney disease (CKD). We assessed the efficacy of short-term Dapa administration following acute kidney injury (AKI) in preventing CKD. Male Wistar rats were randomly assigned to Sham surgery, bilateral ischemia for 30 minutes (abbreviated as IR), and IR + Dapa groups. Daily treatment with Dapa was initiated just 24 hours after IR and maintained for only 10 days. Initially, rats were euthanized at this point to study early renal repair. After severe AKI, Dapa promptly restored creatinine clearance (CrCl) and significantly reduced renal vascular resistance compared with the IR group. Furthermore, Dapa effectively reversed the mitochondrial abnormalities, including increased fission, altered mitophagy, metabolic dysfunction, and proapoptotic signaling. To study this earlier, another set of rats was studied just 5 days after AKI. Despite persistent renal dysfunction, our data reveal a degree of mitochondrial protection. Remarkably, a 10-day treatment with Dapa demonstrated effectiveness in preventing CKD transition in an independent cohort monitored for 5 months after AKI. This was evidenced by improvements in proteinuria, CrCl, glomerulosclerosis, and fibrosis. Our findings underscore the potential of Dapa in preventing maladaptive repair following AKI, emphasizing the crucial role of early intervention in mitigating AKI long-term consequences.
    MeSH term(s) Animals ; Humans ; Male ; Rats ; Acute Kidney Injury/drug therapy ; Acute Kidney Injury/prevention & control ; Acute Kidney Injury/metabolism ; Glucose ; Rats, Wistar ; Renal Insufficiency, Chronic/drug therapy ; Reperfusion Injury/complications ; Reperfusion Injury/metabolism ; Sodium/metabolism ; Sodium-Glucose Transporter 2/drug effects ; Sodium-Glucose Transporter 2 Inhibitors/pharmacology ; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use ; Benzhydryl Compounds/pharmacology ; Benzhydryl Compounds/therapeutic use
    Chemical Substances Glucose (IY9XDZ35W2) ; Sodium (9NEZ333N27) ; Sodium-Glucose Transporter 2 ; dapagliflozin (1ULL0QJ8UC) ; Sodium-Glucose Transporter 2 Inhibitors ; Benzhydryl Compounds
    Language English
    Publishing date 2024-02-22
    Publishing country United States
    Document type Journal Article
    ISSN 2379-3708
    ISSN (online) 2379-3708
    DOI 10.1172/jci.insight.173675
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: The many faces of Mac-1 in autoimmune disease.

    Rosetti, Florencia / Mayadas, Tanya N

    Immunological reviews

    2016  Volume 269, Issue 1, Page(s) 175–193

    Abstract: Mac-1 (CD11b/CD18) is a β2 integrin classically regarded as a pro-inflammatory molecule because of its ability to promote phagocyte cytotoxic functions and enhance the function of several effector molecules such as FcγR, uPAR, and CD14. Nevertheless, ... ...

    Abstract Mac-1 (CD11b/CD18) is a β2 integrin classically regarded as a pro-inflammatory molecule because of its ability to promote phagocyte cytotoxic functions and enhance the function of several effector molecules such as FcγR, uPAR, and CD14. Nevertheless, recent reports have revealed that Mac-1 also plays significant immunoregulatory roles, and genetic variants in ITGAM, the gene that encodes CD11b, confer risk for the autoimmune disease systemic lupus erythematosus (SLE). This has renewed interest in the physiological roles of this integrin and raised new questions on how its seemingly opposing biological functions may be regulated. Here, we provide an overview of the CD18 integrins and how their activation may be regulated as this may shed light on how the opposing roles of Mac-1 may be elicited. We then discuss studies that exemplify Mac-1's pro-inflammatory versus regulatory roles particularly in the context of IgG immune complex-mediated inflammation. This includes a detailed examination of molecular mechanisms that could explain the risk-conferring effect of rs1143679, a single nucleotide non-synonymous Mac-1 polymorphism associated with SLE.
    MeSH term(s) Animals ; CD11b Antigen/genetics ; CD11b Antigen/metabolism ; Genetic Predisposition to Disease ; Humans ; Immune Complex Diseases/immunology ; Immunomodulation ; Lupus Erythematosus, Systemic/immunology ; Phagocytosis ; Polymorphism, Genetic ; Risk
    Chemical Substances CD11b Antigen ; ITGAM protein, human
    Language English
    Publishing date 2016-01
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 391796-4
    ISSN 1600-065X ; 0105-2896
    ISSN (online) 1600-065X
    ISSN 0105-2896
    DOI 10.1111/imr.12373
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Sexually Transmitted Infection Testing, Prevalence, and Treatment Among Individuals Receiving HIV Preexposure Prophylaxis Within an Integrated Healthcare Delivery System.

    Schmidt, Mark A / Dickerson, John F / O'Keeffe-Rosetti, Maureen C / Salas, Suzanne B / Donald, Judy L / Tao, Guoyu

    Sexually transmitted diseases

    2022  Volume 49, Issue 9, Page(s) 616–621

    Abstract: Background: Initial and follow-up sexually transmitted infection (STI) and human immunodeficiency virus (HIV) testing are recommended when taking HIV preexposure prophylaxis (PrEP). We assessed STI services before and after PrEP initiation among persons ...

    Abstract Background: Initial and follow-up sexually transmitted infection (STI) and human immunodeficiency virus (HIV) testing are recommended when taking HIV preexposure prophylaxis (PrEP). We assessed STI services before and after PrEP initiation among persons 18 years or older.
    Methods: We conducted this retrospective cohort study at a US integrated healthcare delivery system. We measured HIV/STI testing rates, STI prevalence and treatment at 3 time points: (1) at PrEP initiation, (2) at 120 days, and (3) at 210 days.
    Results: Of 685 PrEP initiators, 67.2% continued PrEP use at 120 days and 49.5% at 210 days. Of PrEP users, HIV and STI testing were greater than 85% and greater than 80%, respectively, at all 3 time points. Prevalence for any chlamydia, rectal chlamydia, and any gonorrhea, rectal gonorrhea, or pharyngeal gonorrhea was always high at the 120 days and 210 days (eg, 6.9%, 10.5%, 6.7%, 5.0%, and 5.2%, respectively, at the 120 days for continuous PrEP users). Over 90% of all individuals who tested positive for chlamydia and gonorrhea received antibiotic pharmacy fills within 7 days at 120 and 210 days. Monthly PrEP-related pharmacy cost was about $2259 to $2659. The proportion of the total medical cost that was PrEP-related pharmacy was about 82% for PrEP continuous users.
    Conclusions: Although HIV/STI testing rates were high, they can still be improved during HIV PrEP management. High STI prevalence after PrEP initiation in this study suggests that patients taking PrEP are at risk of acquiring an STI. Interventions to improve STI services during PrEP management are continuously needed.
    MeSH term(s) Delivery of Health Care, Integrated ; Gonorrhea/diagnosis ; Gonorrhea/drug therapy ; Gonorrhea/epidemiology ; HIV Infections/diagnosis ; HIV Infections/drug therapy ; HIV Infections/epidemiology ; Homosexuality, Male ; Humans ; Male ; Pre-Exposure Prophylaxis ; Prevalence ; Retrospective Studies ; Sexually Transmitted Diseases/diagnosis ; Sexually Transmitted Diseases/drug therapy ; Sexually Transmitted Diseases/epidemiology
    Language English
    Publishing date 2022-06-17
    Publishing country United States
    Document type Journal Article ; Research Support, U.S. Gov't, P.H.S.
    ZDB-ID 435191-5
    ISSN 1537-4521 ; 0148-5717
    ISSN (online) 1537-4521
    ISSN 0148-5717
    DOI 10.1097/OLQ.0000000000001665
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top